Lead Story Picture
American Express and a group of merchants challenging the credit card company's rules blocking retailers from encouraging customers to use other potentially cheaper credit card brands reached the deal in late 2013. (Credit: AP)

BREAKING: AmEx Judge Rejects Merchant Deal Over Atty 'Collusion'

A New York federal judge on Tuesday rejected a proposed class action settlement in the antitrust litigation merchants brought against American Express Co., saying the frequent exchange of confidential information that one of the lead plaintiffs' attorneys shared with counsel for MasterCard Inc. "smacks of blatant collusion."

  • Faruqi, Ex-Lawyer Settle 2nd Circ. Sex Harassment Row

    Faruqi & Faruqi LLP and former associate Alexandra Marchuk, who won a $140,000 judgment in her sexual harassment suit against the firm, agreed to settle their dispute at the Second Circuit, a few months after the parties filed cross-appeals following the jury trial that left neither side pleased with the outcome.

  • House Ethics Panel To Probe Pa. Rep. Following Indictment

    The U.S. House of Representatives’ Ethics Committee on Monday said it is opening an investigation into whether Congressman Chaka Fattah Sr., D-Pa., violated House rules in light of bribery and fraud charges filed in connection with his failed Philadelphia mayoral bid.

  • Bayer Agrees To $57M Deal To End Yaz Blood Clot Suits

    Bayer Corp. has agreed to pay nearly $57 million to end a series of lawsuits across multiple federal and state jurisdictions over allegations that use of its birth control pills Yaz, Yasmin and Ocella resulted in strokes and heart attacks.

  • BREAKING: Record $1.5B Marvell Verdict Slashed To $278M By Fed. Circ.

    The Federal Circuit on Tuesday significantly reduced the record $1.54 billion judgment that Carnegie Mellon University won against Marvell Technology Group Ltd. in a disk drive patent suit, leaving $278 million in damages intact and ordering a new trial to recalculate the remaining amount.

  • Shire Lobs $30B Unsolicited Offer For Baxalta

    Irish drugmaker Shire PLC said Tuesday that it has made an unsolicited stock bid valued around $30 billion to acquire U.S. biotech Baxalta Inc., aiming for a tie-up that would create a biotech giant focused on treatments for rare diseases.

  • Jury Adds $3.2M Punitive Damages To Philip Morris Verdict

    A Florida jury on Monday slapped Philip Morris USA Inc. with $3.2 million in punitive damages, awarding a total of $11 million to the family of an ex-smoker who had two lung transplants after decades of smoking.


Follow our exclusive coverage of the trial of the year:

Catch up on the Dewey trial here